Antisense modulation of CoREST expression
AssigneeIsis Pharmaceuticals, Inc.
InventorsC. Frank Bennett, Susan M. Freier
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of CoREST. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding CoREST. Methods of using these compounds for modulation of CoREST expression and for treatment of diseases associated with expression of CoREST are provided.
Claims20
A compound 8 to 50 nucleobases in length targeted to a nucleic acid molecule encoding CoREST, wherein said compound specifically hybridizes with said nucleic acid molecule encoding CoREST and inhibits the expression of CoREST.
A compound 8 to 50 nucleobases in length which specifically hybridizes with at least an 8-nucleobase portion of an active site on a nucleic acid molecule encoding CoREST.
Dependencies are inferred from the claim text.